Chronic hepatitis C and sarcoidosis are both well-known diseases. Some studies support the hypothesis that the hepatitis C virus (HCV) may trigger sarcoidosis . We present a case of (1) chronic hepatitis C, developing a silent lung systemic disease with subcutaneous and ganglionar nodules, ultimately proving to be sarcoidosis. The clinical picture is complicated by a hepatic nodule, challenging the treatment course. The unveiling of a sarcoidosis in a previously HCV infected patient may not be accidental, the course of infection could be influenced by systemic disease. The therapy of chronic hepatitis C in the context of sarcoidosis is very challenging and demands a careful monitoring . (2) Rezumat Hepatita cronică virală C și sarcoidoza nu sunt neobișnuite, infec ia cu VHC fiind o problemă globală frecventă, iar sarcoidoza o boală cunoscută în practica medicală. Există studii care sus in că infec ia cu virus C crește riscul de sarcoidoză . (1) Prezentăm cazul unei paciente în vârstă de 70 de ani cunoscută cu infec ie cronică virală C, care dezvoltă determinări subcutante și ganglionare multiple în cadrul unei boli sistemice ce se dovedește a fi sarcoidoză cu implicare pulmonară silen ioasă. Tabloul este complicat de apari ia unui nodul hepatic ce a generat provocări diagnostice și terapeutice. Diagnosticul anatomopatologic infirmă etiologia malignă, sarcoidoza hepatică sau ciroză hepatică. Apari ia sarcoidozei la o pacientă cu infec ie virală C poate să nu fie întâmplătoare, iar stadializarea bolii hepatice poate fi influen ată de boala sistemică. Conduita terapeutică în infec ia virală C la pacien ii cu sarcoidoză este o provocare pentru clinician și implică o monitorizare atentă ² . ( ) Cuvinte cheie: sarcoidoză, ciroză hepatica, hepatită cronică virală C.
Introduction
The name of sarcoidosis dates back to 1899, when Caesar Boeck histopathologically described the cutaneous nodules in a patient suffering from this disease, although the trigger mechanism of this illness is not known . It appears that sarcoid granulomas (1) would result from a hypersensitivity reaction in response to an extrinsic or intrinsic antigen in genetically susceptible individuals . The (3) m a i n f e a t u r e o f s a r c o i d o s i s i s t h e accumulation of granulomas in tissues, with dimensions ranging from 50 to 300 mm , (4) any organ being affected.
Sarcoidosis affects women predominantly, and two peaks occurring between 25 and 40 years old and after 50 years of age re s p e c t i v e l y a re d e s c r i b e d . T h i s i s responsible for 12-30% of cases of liver granulomas . (4) The prevalence of sarcoidosis among patients with hepatitis C virus infection is 0.1-0.2% ² and there are studies claiming that ( ) (6) hepatitis C virus infection increases the risk of sarcoidosis .
(1)
Case presentation
A 
Discussion
The case is special in terms of diagnostic challenge, coexistence of the two diseases: Extrapulmonary affection is common and can affect any organ in sarcoidosis, but the isolated extrapulmonary affection is rare, less than 10% of cases are described in the literature . (7) Pulmonary manifestations were rough, visible only at CT examination. Thoracic radiography, which in 90% of cases of sarcoidosis is abnormal, showing lymphadenopathy and/or fibrosis , in this case it did not raise such (5) suspicion.
The first diagnostic assumption was 
Liver involvement in sarcoidosis is usually asymptomatic, therefore it is clinically underdiagnosed and frequently found in late stages of cirrhosis and liver failure. Frequent i n c re a s e s i n G GT ( g a m m a g l u t a m y l transpeptidase) and alkaline phosphatase levels are found. 17 Hepatic impairment was found in 70% of autopsy patients in a Japanese study . According to some authors it is likely that in 1 fact the treatment with interpheron alfa, through the rise of TNF gamma and IL2 stimulates the formation of granuloma. In chronic C hepatitis, the possibility of hepatic granuloma is described (0,8-9,5% of positive biopsies for granuloma before the initiation of interpheron treatment) . (2, 19) These aspects indicate the possibility of a l The therapeutic approach in C viral infection in patients with sarcoidosis is a challenge for the clinician and implies a careful monitoring . (2) 
